Evidence map›Paper›PMID 42757050›Full record

ArticleThe Lancet regional health. Western Pacific2026

Trends in

Dianqin Sun, Weiran Han, Fernando Alarid-Escudero, Jorge A Roa-Contreras, Shaoming Wang, Duco T Mülder, Robert J Huang, Uri Ladabaum, Manon C W Spaander, M Constanza Camargo and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dianqin SunDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Weiran HanDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Fernando Alarid-EscuderoDepartment of Health Policy, School of Medicine, Stanford University, Stanford, CA, United States.
Jorge A Roa-ContrerasDepartment of Health Policy, School of Medicine, Stanford University, Stanford, CA, United States.
Shaoming WangNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Duco T MülderDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Robert J HuangDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, United States.
Uri LadabaumDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, United States.
Manon C W SpaanderDepartment of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
M Constanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, United States.
Jin Young ParkEarly Detection, Prevention, and Infections Branch, International Agency for Research on Cancer, Lyon, France.
Wanqing ChenNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Iris Lansdorp-VogelaarDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Jan A C HontelezDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Funding

PRECISE - a PErsonalized Risk Score for gastrIc CancErK08CA252635 · NCI · STANFORD UNIVERSITY · PI HUANG, ROBERT JEFFREY · 2021 to 2025
$941k
NCI NIH HHS K08 CA252635
6 · The paper itself

Abstract

Background: Methods: We systematically reviewed studies reporting Findings: We included 181 studies in the Bayesian model fitting. Cohorts born after 1980 experienced substantially lower childhood FOI than earlier cohorts, indicating reduced early-life acquisition. However, population prevalence declined only modestly, from 43.1% (95% credible interval 39.1-47.4) in 1990 to 36.3% (33.2-39.6) in 2023. In 2023, estimated PAFs were 70.1% (95% uncertainty interval 51.4-82.4) for non-cardia GC and 49.4% (20.5-70.7) for cardia GC. Interpretation: Funding: China Scholarship Council, EU4Health.

Indexed as

Bayesian catalytic modelChinaForce of infectionHelicobacter pyloriStomach cancer

Identifiers

PMID42757050
PMCPMC13584135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.